Bortezomib Sandoz 3.5 mg, Pulver zur Herstellung einer Injektionslösung

7680671670028 CH-67167 Pulver
Bortezomib Sandoz 3.5 mg, Pulver zur Herstellung einer Injektionslösung
Bortezomib Sandoz 3.5 mg, Pulver zur Herstellung einer Injektionslösung
Bortezomib Sandoz 3.5 mg, Pulver zur Herstellung einer Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/04/2024
Summary of Product Characteristics
Français
10/04/2024
Summary of Product Characteristics
Italien
10/04/2024

Detailed composition

Substance Quantity Type Category
(N/A)
3.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 421.85
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2020

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
67167
Drug name
Bortezomib Sandoz, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULPA
ATC Code
L01XG01
Authorization status
Z
Dispensing category
A
First authorization
13/11/2018
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
BORTEZOMIB Sandoz subst sèche 3.5 mg flac
Description (DE)
BORTEZOMIB Sandoz Trockensub 3.5 mg Durchstf
Market launch
13/11/2018
Narcotic (BTM)
No

Original drug

Velcade, Lyophilisat zur Herstellung einer Injektionslösung
GTIN: 7680569760015
CHF 460.10
View original

Other package sizes (1)

BORTEZOMIB Sandoz subst sèche 1 mg flac
1 DUR
GTIN: 7680671670011
View